Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Oncology market: From $286B to $581B (2030)

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison May 08, 2023 1:33pm

143 Views

Post# 35436747

RE:Oncology market: From $286B to $581B (2030)

Interesting statistic ScienceFirst however those figures have been calculated on current treatments, Theralase's treatment as we are much less costly thereby greatly reducing the expense to individuals and insurance companies. There are so many pluses with Theralase's treatment that when it does get media attention this company will become the main sensation in my not so humble opinion.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages